VEGF as a Marker for Outcome Among Advanced Breast Cancer Patients Receiving anti-VEGF Therapy with Bevacizumab and Vinorelbine Chemotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

VEGF as a Marker for Outcome Among Advanced Breast Cancer Patients Receiving anti-VEGF Therapy with Bevacizumab and Vinorelbine Chemotherapy

Published:2008-12-01 Issue:23 Volume:14 Page:7871-7877
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Burstein Harold J.,Chen Yu-Hui,Parker Leroy M.,Savoie Jennifer,Younger Jerry,Kuter Irene,Ryan Paula D.,Garber Judy E.,Chen Helen,Campos Susana M.,Shulman Lawrence N.,Harris Lyndsay N.,Gelman Rebecca,Winer Eric P.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-VEGF therapy selects for clones resistant to glucose starvation in ovarian cancer xenografts;Journal of Experimental & Clinical Cancer Research;2023-08-07

2. Ramucirumab Plus Docetaxel for Patients with Non-small cell Lung Cancer with Brain Metastases: A Multicenter, Open-Label Single-Arm Phase II Trial;The Oncologist;2023-04-13

3. An angiogenic tumor phenotype predicts poor prognosis in ovarian cancer;Gynecologic Oncology;2023-03

4. Tumor Angiogenesis;Holland‐Frei Cancer Medicine;2022-10-21

5. Prognostic Value and Biological Role of miR-126 in Breast Cancer;MicroRNA;2022-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP